APOBEC3G Activators

APOBEC3G, often abbreviated as A3G, is a cytidine deaminase that plays a significant role in inhibiting retroviral replication, particularly HIV-1, by introducing mutations into the viral genome. Given its role in viral restriction, chemicals that activate or upregulate A3G can be of significant interest. This class of chemicals, termed APOBEC3G Activators, comprises compounds that can either directly or indirectly enhance A3G activity or expression.Resveratrol, a natural polyphenol, has been observed to elevate A3G expression in specific cell lines. Another compound, Prostratin, activates the NF-κB pathway, which in turn results in increased A3G expression. 5-Aza-2'-deoxycytidine (AZA), a demethylating agent, can also upregulate A3G expression. Furthermore, the compound Epigallocatechin-3-gallate (EGCG) is known to augment A3G's incorporation into HIV-1 virions, thereby amplifying its antiviral effects.

Additionally, compounds like Curcumin are known to escalate A3G expression under certain conditions. Sodium Butyrate, a histone deacetylase inhibitor, can modulate A3G expression, while Disulfiram can influence A3G levels, although its primary action is as an aldehyde dehydrogenase inhibitor. JQ1, a BET bromodomain inhibitor, is another compound that can affect A3G activity, though this effect may be indirect. Rapamycin, an mTOR inhibitor, and Tumor Necrosis Factor-alpha (TNF-α), a pro-inflammatory cytokine, are additional examples that can modulate cellular processes, leading to changes in A3G activity or expression.